BGI Genomics Co., Ltd. (SHE:300676)
32.78
-1.61 (-4.68%)
Nov 20, 2026, 3:04 PM CST
BGI Genomics Market Cap
BGI Genomics has a market cap or net worth of 12.58 billion as of November 20, 2026. It is the 6,467th most valuable company in the world and the 1,121st biggest in China. Its market cap has decreased by 31.44% in one year.
Market Cap
12.58B
Enterprise Value
10.25B
Revenue
3.72B
Global Rank
Country Rank
#1,121 China
PE Ratio
n/a
ChartMarket Cap Chart
Since July 14, 2017, BGI Genomics's market cap has increased from 7.86B to 12.58B, an increase of 60.12%. That is a compound annual growth rate of 5.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 12.58B | -27.73% |
| Dec 31, 2025 | 17.41B | 8.78% |
| Dec 31, 2024 | 16.01B | -18.66% |
| Dec 29, 2023 | 19.68B | -7.14% |
| Dec 30, 2022 | 21.19B | -41.13% |
| Dec 31, 2021 | 35.99B | -29.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Tigermed Consulting | 34.83B |
| Joinn Laboratories(China)Co.,Ltd. | 21.80B |
| Guangzhou Kingmed Diagnostics Group | 12.05B |
| Dian Diagnostics Group | 10.60B |
| Beijing Strong Biotechnologies,Inc. | 7.00B |
| Amoy Diagnostics | 6.29B |
| Shanghai Runda Medical Technology | 4.42B |
| Cowealth Medical China | 3.41B |